RFC
JNP

Russell Frank Company’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Russell Frank Company’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$7K – 3227
2013
Q3 		$7K Buy
+1,000
New +$6.73K ﹤0.01% 3303

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Russell Frank Company's JNP Position: Q4 2013 in Review

Russell Frank Company sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2013, closing a stake of 1,000 shares — an estimated $7K sold.

Russell Frank Company first reported a position in JNP in Q3 2013 and held it in 1 quarter. The position peaked at $7K in Q3 2013. 31 funds tracked by Wall St. Rank hold JNP as of Q4 2013.

  • Russell Frank Company reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 1,000 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2013, an estimated $7K.
  • Russell Frank Company first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Russell Frank Company's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.